Insulin like growth factor-1 (IGF-1) causes overproduction of IL-8, an angiogenic cytokine and stimulates neovascularization in isoproterenol-induced myocardial infarction in rats
- PMID: 22272091
- PMCID: PMC3257088
- DOI: 10.3390/ijms12128562
Insulin like growth factor-1 (IGF-1) causes overproduction of IL-8, an angiogenic cytokine and stimulates neovascularization in isoproterenol-induced myocardial infarction in rats
Abstract
Angiogenesis factors are produced in response to hypoxic or ischemic insult at the site of pathology, which will cause neovascularization. Insulin like growth factor-1 (IGF-1) exerts potent proliferative, angiogenic and anti-apoptotic effects in target tissues. The present study was aimed to evaluate the effects of IGF-1 on circulating level of angiogenic cytokine interleukin-8 (IL-8), in experimentally-induced myocardial ischemia in rats. Male Sprague-Dawley rats were divided into control, IGF-1 treated (2 μg/kg/day subcutaneously, for 5 and 10 days), isoproterenol (ISO) treated (85 mg/kg, subcutaneously for two days) and ISO with IGF-1 treated (for 5 and 10 days). Heart weight, serum IGF-1, IL-8 and cardiac marker enzymes (CK-MB and LDH) were recorded after 5 and 10 days of treatment. Histopathological analyses of the myocardium were also done. There was a significant increase in serum cardiac markers with ISO treatment indicating myocardial infarction in rats. IGF-1 level increased significantly in ISO treated groups and the level of IGF-1 was significantly higher after 10 days of treatment. IL-8 level increased significantly after ISO treatment after 5 and 10 days and IGF-1 concurrent treatment to ISO rats had significantly increased IL-8 levels. Histopathologically, myocyte necrosis and nuclear pyknosis were reduced significantly in IGF-1 treated group and there were numerous areas of capillary sprouting suggestive of neovascularization in the myocardium. Thus, IGF-1 protects the ischemic myocardium with increased production of circulating angiogenic cytokine, IL-8 and increased angiogenesis.
Keywords: IGF-1; angiogenesis; interleukin-8; isoproterenol; myocardial ischemia.
Figures

Similar articles
-
Insulin-Like Growth Factor-1 (IGF-1) Reduces ischemic changes and increases circulating angiogenic factors in experimentally - induced myocardial infarction in rats.Vasc Cell. 2011 Jun 9;3(1):13. doi: 10.1186/2045-824X-3-13. Vasc Cell. 2011. PMID: 21651821 Free PMC article.
-
Enhancement of cardiac angiogenesis in a myocardial infarction rat model using selenium alone and in combination with PTXF: the role of Akt/HIF-1α signaling pathway.Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul;397(7):4677-4692. doi: 10.1007/s00210-023-02904-9. Epub 2023 Dec 19. Naunyn Schmiedebergs Arch Pharmacol. 2024. Retraction in: Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):4665. doi: 10.1007/s00210-025-03935-0. PMID: 38112730 Free PMC article. Retracted.
-
Kampeferol protects against oxidative stress and apoptotic damage in experimental model of isoproterenol-induced cardiac toxicity in rats.Phytomedicine. 2016 Nov 15;23(12):1401-1408. doi: 10.1016/j.phymed.2016.07.015. Epub 2016 Aug 4. Phytomedicine. 2016. PMID: 27765360
-
Protective effect of alpha-pinene against isoproterenol-induced myocardial infarction through NF-κB signaling pathway.Hum Exp Toxicol. 2020 Dec;39(12):1596-1606. doi: 10.1177/0960327120934537. Epub 2020 Jun 30. Hum Exp Toxicol. 2020. PMID: 32602371
-
Effects of carnosine on prooxidant-antioxidant status in heart tissue, plasma and erythrocytes of rats with isoproterenol-induced myocardial infarction.Pharmacol Rep. 2014 Feb;66(1):81-6. doi: 10.1016/j.pharep.2013.08.008. Epub 2014 Feb 1. Pharmacol Rep. 2014. PMID: 24905311
Cited by
-
Pathophysiological Effects of Various Interleukins on Primary Cell Types in Common Heart Disease.Int J Mol Sci. 2023 Mar 30;24(7):6497. doi: 10.3390/ijms24076497. Int J Mol Sci. 2023. PMID: 37047468 Free PMC article. Review.
-
The impact of circulating IGF-1 and IGFBP-2 on cardiovascular prognosis in patients with acute coronary syndrome.Front Cardiovasc Med. 2023 Mar 10;10:1126093. doi: 10.3389/fcvm.2023.1126093. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36970368 Free PMC article.
-
Delivery of biotinylated IGF-1 with biotinylated self-assembling peptides combined with bone marrow stem cell transplantation promotes cell therapy for myocardial infarction.Exp Ther Med. 2017 Oct;14(4):3441-3446. doi: 10.3892/etm.2017.4982. Epub 2017 Aug 21. Exp Ther Med. 2017. PMID: 29042931 Free PMC article.
-
The role of exercise-induced myokines in promoting angiogenesis.Front Physiol. 2022 Aug 26;13:981577. doi: 10.3389/fphys.2022.981577. eCollection 2022. Front Physiol. 2022. PMID: 36091401 Free PMC article. Review.
-
Cardiometabolic Changes in Response to a Calorie-Restricted DASH Diet in Obese Older Adults.Front Nutr. 2021 Mar 19;8:647847. doi: 10.3389/fnut.2021.647847. eCollection 2021. Front Nutr. 2021. PMID: 33816541 Free PMC article.
References
-
- Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671–674. - PubMed
-
- Hudlicka O., Brown M., Egginton S. Angiogenesis in skeletal and cardiac muscle. Physiol. Rev. 1992;72:369–417. - PubMed
-
- Zielonka T.M., Demkow U., Filewska M., Bialas B., Korczynski P., Szopinski J. Angiogenic activity of sera from interstitial lung diseases patients in relation to IL-6, IL-8, IL-12 and TNF-α serum level. Centr. Eur. J. Immunol. 2007;32:53–60.
-
- Entman M.L., Michael L., Rossen R.D., Dreyer W.J., Anderson D.C., Taylor A.A. Inflammation in the course of early myocardial ischemia. FASEB J. 1991;5:2529–2537. - PubMed
-
- Kastrup J. Therapeutic angiogenesis in ischemic heart disease: gene or recombinant vascular growth factor protein therapy? Curr. Gene Ther. 2003;3:197–206. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous